GV-58
Selective N- and P/Q-type Ca2+-channel agonist. These Ca2+-channels regulate transmitter release in synapses. Potential lead compound for a variety of disorders that result in neuromuscular weakness.
| Catalog Number | AG-MR-C0035-M005 |
| Alternative Name(s) | (2R)-2-[(6-{[(5-Methylthiophen-2-yl)methyl]amino}-9-propyl-9H-purin-2-yl)amino]butan-1-ol; Rx-ID: 23159892 |
| Research Area | Biochemicals, Immunology, Inflammation, Neurobiology, Neurodegenerative Disease |
| Molecular Formula | C18H26N6OS |
| Purity | >97% |
| Inchi | InChI=1S/C18H26N6OS/c1-4-8-24-11-20-15-16(19-9-14-7-6-12(3)26-14)22-18(23-17(15)24)21-13(5-2)10-25/h6-7,11,13,25H,4-5,8-10H2,1-3H3,(H2,19,21,22,23)/t13-/m1/s1 |
| Inchi Key | DPTXJOUVBMUSGY-CYBMUJFWSA-N |
| SMILES | CCCN1C=NC2=C(NCC3=CC=C(C)S3)N=C(N[C@H](CC)CO)N=C12 |
| Size | 5 mg |
| Supplier Page | http://www.adipogen.com/mr-c0035/gv-58.html |